⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked stocksUnlock stocks

eThema Health's Eileen Maria Greene acquires $22,046 in common stock

Published 23/11/2024, 02:24
eThema Health's Eileen Maria Greene acquires $22,046 in common stock
GRST
-

Eileen Maria Greene, a related party of eThema Health Corp (OTC:GRST), has acquired a total of 44,092,551 shares of common stock, according to a recent SEC filing. These transactions, which took place on November 20 and 21, were executed at a price of $0.0005 per share, amounting to a total value of $22,046. Following these acquisitions, Greene's direct ownership in eThema Health stands at 1,099,199,593 shares.

InvestingPro Insights

The recent acquisition of shares by Eileen Maria Greene comes at a time when eThema Health Corp (OTC:GRST) is facing significant financial challenges. According to InvestingPro data, the company's market capitalization stands at a modest $3.86 million, reflecting its microcap status.

InvestingPro Tips highlight that GRST operates with a significant debt burden and its short-term obligations exceed liquid assets. This financial strain is further evidenced by the company's negative operating income margin of -33.71% for the last twelve months as of Q3 2024.

Despite these challenges, GRST has shown some positive signs. The company's revenue growth (quarterly) for Q3 2024 was 29.99%, indicating potential for improvement. However, this growth has not yet translated into profitability, as InvestingPro Tips note that GRST is not profitable over the last twelve months.

The stock's recent performance has been volatile. InvestingPro data shows that GRST's stock price has fallen significantly over the last three months, with a 3-month price total return of -37.5%. This decline is consistent with the InvestingPro Tip suggesting that the stock has taken a big hit over the last week.

For investors seeking a more comprehensive analysis, InvestingPro offers 8 additional tips for GRST, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.